X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12) 12
humans (9) 9
male (8) 8
animals (7) 7
pharmacology & pharmacy (7) 7
transport (5) 5
cornea (4) 4
pharmacology/toxicology (4) 4
prodrugs - chemistry (4) 4
absorption (3) 3
acyclovir (3) 3
antiviral agent (3) 3
biochemistry, general (3) 3
biotechnology (3) 3
chemistry (3) 3
cornea - metabolism (3) 3
medicine, research & experimental (3) 3
nucleobase (3) 3
nucleoside (3) 3
original (3) 3
peptides (3) 3
permeability (3) 3
pharmacy (3) 3
physicochemical properties (3) 3
prodrugs - metabolism (3) 3
rabbits (3) 3
sirc (3) 3
adolescent (2) 2
adult (2) 2
apixaban (2) 2
area under curve (2) 2
article (2) 2
biological transport, active (2) 2
biomedicine (2) 2
biotechnology & applied microbiology (2) 2
brain - metabolism (2) 2
brain targeting (2) 2
care and treatment (2) 2
carrier mediated transport (2) 2
chemical derivatisation (2) 2
clinical trials (2) 2
cross-over studies (2) 2
disposition (2) 2
drug delivery systems (2) 2
drug design (2) 2
drug stability (2) 2
female (2) 2
human necessities (2) 2
hydrogen-ion concentration (2) 2
hygiene (2) 2
in vitro techniques (2) 2
intestinal absorption (2) 2
keratitis (2) 2
l-alpha-methyldopa (2) 2
medical or veterinary science (2) 2
membrane transport proteins - metabolism (2) 2
metallurgy (2) 2
middle aged (2) 2
models, biological (2) 2
mutation (2) 2
nasal drug delivery (2) 2
organic chemistry (2) 2
patients (2) 2
penetration (2) 2
pharmacokinetics (2) 2
preparations for medical, dental, or toilet purposes (2) 2
prodrug (2) 2
prodrugs (2) 2
prodrugs - pharmacokinetics (2) 2
progressive supranuclear palsy (2) 2
pyrazoles - adverse effects (2) 2
pyrazoles - pharmacokinetics (2) 2
pyridones - adverse effects (2) 2
pyridones - pharmacokinetics (2) 2
rats (2) 2
safety (2) 2
solubility (2) 2
specific therapeutic activity of chemical compounds ormedicinal preparations (2) 2
sugar-conjugated compounds (2) 2
usage (2) 2
-propranolol (1) 1
2-hydroxypropyl-beta-cyclodextrin (1) 1
absorptive mucosae (1) 1
acceleration (1) 1
active absorption (1) 1
active transport (1) 1
acylation (1) 1
adenine - metabolism (1) 1
adenine-arabinoside (1) 1
administration, intranasal (1) 1
administration, oral (1) 1
adrenergic beta-antagonists - metabolism (1) 1
adsorption (1) 1
age (1) 1
alzheimer's disease (1) 1
alzheimers disease (1) 1
amino acid transport systems - metabolism (1) 1
analysis (1) 1
anti-drug antibodies (1) 1
antibodies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Hepatology, ISSN 0168-8278, 04/2019, Volume 70, Issue 1, pp. e798 - e798
Journal Article
CPT: Pharmacometrics & Systems Pharmacology, ISSN 2163-8306, 09/2017, Volume 6, Issue 9, pp. 596 - 603
The 6‐minute walk test (6MWT) is used as a clinical endpoint to evaluate drug efficacy in Duchenne Muscular Dystrophy (DMD) trials. A model was developed using... 
Models, Biological | Muscular Dystrophy, Duchenne - physiopathology | Humans | Adolescent | Child, Preschool | Male | Walk Test | Child | Disease Progression | Mortality | Population | Digitization | Muscle function | Mutation | Drug therapy | Patients | Natural history | Age | Muscular dystrophy | Index Medicus | Original
Journal Article
CPT: Pharmacometrics & Systems Pharmacology, ISSN 2163-8306, 09/2017, Volume 6, Issue 9, pp. 596 - 603
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 05/1999, Volume 88, Issue 5, pp. 544 - 550
Journal Article
Alzheimer's & Dementia: Translational Research & Clinical Interventions, ISSN 2352-8737, 2018, Volume 4, pp. 746 - 755
Extracellular tau is hypothesized to mediate the onset and progression of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and a... 
Tau | Phase 1 | Tauopathy | Progressive supranuclear palsy | Alzheimer's disease
Journal Article
12/2018
Dosage regimens and formulations of anti-human tau antibodies are provided. These formulations and dosage regimens find use in the treatment of tauopathies... 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | METALLURGY | PEPTIDES | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | ORGANIC CHEMISTRY | CHEMISTRY | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
Expert Opinion on Therapeutic Patents, ISSN 1354-3776, 03/2002, Volume 12, Issue 3, pp. 331 - 340
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.